» Articles » PMID: 8605724

CD44 Exon Variant 6 Epitope and Hyaluronate Synthase Are Expressed on HT29 Human Colorectal Carcinoma Cells in a SCID Mouse Model of Metastasis Formation

Overview
Specialty Oncology
Date 1996 Mar 1
PMID 8605724
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The factors which lead to the formation of metastases are generally poorly understood; however the expression of a particular variant of the cell adhesion molecule CD44 may be important in facilitating metastasis formation in colon cancer. The aim of the present study was to investigate the expression of CD44 exon v 6 (CD44v6), hyaluronate (one of its ligands), and hyaluronate synthase, in a clinically relevant animal model of metastatic colon carcinoma. HT29 human colon carcinoma cells were injected subcutaneously between the scapulae of severe combined immunodeficient (SCID) mice and left for 3 weeks (by which time the tumours had produced metastases in the lungs). Morphological observations at the tumour-host interface were consistent with the dissociation of neoplastic cells from the primary tumours, and the ability of these cells to migrate through the extracellular matrix facilitating metastasis formation. Immunohistochemically detectable hyaluronate synthase expression was increased in vivo compared with the parent cell line in vitro. CD44v6 expression and hyaluronate were increased around single cells at the periphery of tumours compared with the central regions. CD44v6 and hyaluronate snythase expression were co-expressed in the same cells. Indeed, the present study is the first to demonstrate hyaluronate synthase expression by an epithelial cell type.

Citing Articles

Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells.

Pramanik A, Xu Z, Ingram N, Coletta P, Millner P, Tyler A Mol Pharm. 2022; 19(12):4601-4611.

PMID: 35938983 PMC: 9727730. DOI: 10.1021/acs.molpharmaceut.2c00439.


Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.

Choi K, Jeon E, Yoon H, Lee B, Na J, Min K Biomaterials. 2012; 33(26):6186-93.

PMID: 22687759 PMC: 3617484. DOI: 10.1016/j.biomaterials.2012.05.029.


Immunophenotyping of human HT29 colon cancer cell primary tumours and their metastases in severe combined immunodeficient mice.

Mitchell B, Horny H, Schumacher U Histochem J. 1997; 29(5):393-9.

PMID: 9184853 DOI: 10.1023/a:1026490901926.

References
1.
Jalkanen S, Wu N, Bargatze R, Butcher E . Human lymphocyte and lymphoma homing receptors. Annu Rev Med. 1987; 38:467-76. DOI: 10.1146/annurev.me.38.020187.002343. View

2.
Schumacher U, Higgs D, Loizidou M, Pickering R, Leathem A, Taylor I . Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma. Cancer. 1994; 74(12):3104-7. DOI: 10.1002/1097-0142(19941215)74:12<3104::aid-cncr2820741207>3.0.co;2-0. View

3.
Sofroniew M, Schrell U . Long-term storage and regular repeated use of diluted antisera in glass staining jars for increased sensitivity, reproducibility, and convenience of single- and two-color light microscopic immunocytochemistry. J Histochem Cytochem. 1982; 30(6):504-11. DOI: 10.1177/30.6.6178778. View

4.
Hashimoto K, Yamanishi Y, Maeyens E, Dabbous M, Kanzaki T . Collagenolytic activities of squamous cell carcinoma of the skin. Cancer Res. 1973; 33(11):2790-801. View

5.
Knudson C, Toole B . Epithelial-mesenchymal interaction in the regulation of hyaluronate production during limb development. Biochem Int. 1988; 17(4):735-45. View